-
With the signing of the Productive Economic Association Contract for the development, production and commercialization of Sacha Inchi, Moringa and other natural products, the Strategic Alliance between the ECTI Sierra Maestra and the CNIC is strengthened.
-
The exploratory clinical trial study phase of rectal ozone therapy in positive patients for COVID 19, with mild and moderate symptoms, was successfully completed. Preliminary results indicate that rectal ozone therapy made CRP negative on the 5th day by 40% higher than that achieved by conventional treatment. Such results supported the inclusion of rectal ozone therapy in the national action protocol for COVID 19 of the MINSAP, version 1.5, for the persistent positive COVID 19 patient.
-
The BioCubaFarma Business Group and UK company SG Innovations Limited announce Monday the creation of a new company, BioFarma Innovations, focused on accelerating development and accessibility in Europe and the British Commonwealth of leading and innovative medicines worldwide. The new association aims to provide access to a portfolio of biopharmaceutical products, protected by patents, from BioCubaFarma, which includes the entire pharmaceutical and biotechnology industries established in Cuba.
-
At the soft capsule plant, he reiterated his congratulations on the anniversary of the center and appreciated the ongoing effort of COVID-19 in the production of Sacha Inchi capsules to promote the recovery of critically ill and critically ill patients.
-
Today we received the visit of Dr. Roberto Morales Ojeda, Vice Prime Minister of the Republic of Cuba. Accompanying him on his tour are Dr. Eduardo Martínez, President of BioCubaFarma and other officials.
With the signing of the Productive Economic Association Contract for the development, production and commercialization of Sacha Inchi, Moringa and other natural products, the Strategic Alliance between the ECTI Sierra Maestra and the CNIC is strengthened.
The exploratory clinical trial study phase of rectal ozone therapy in positive patients for COVID 19, with mild and moderate symptoms, was successfully completed. Preliminary results indicate that rectal ozone therapy made CRP negative on the 5th day by 40% higher than that achieved by conventional treatment. Such results supported the inclusion of rectal ozone therapy in the national action protocol for COVID 19 of the MINSAP, version 1.5, for the persistent positive COVID 19 patient.
The BioCubaFarma Business Group and UK company SG Innovations Limited announce Monday the creation of a new company, BioFarma Innovations, focused on accelerating development and accessibility in Europe and the British Commonwealth of leading and innovative medicines worldwide. The new association aims to provide access to a portfolio of biopharmaceutical products, protected by patents, from BioCubaFarma, which includes the entire pharmaceutical and biotechnology industries established in Cuba.
At the soft capsule plant, he reiterated his congratulations on the anniversary of the center and appreciated the ongoing effort of COVID-19 in the production of Sacha Inchi capsules to promote the recovery of critically ill and critically ill patients.
Today we received the visit of Dr. Roberto Morales Ojeda, Vice Prime Minister of the Republic of Cuba. Accompanying him on his tour are Dr. Eduardo Martínez, President of BioCubaFarma and other officials.